355 related articles for article (PubMed ID: 17086809)
21. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2006 Mar; 51(3):217. PubMed ID: 16674021
[No Abstract] [Full Text] [Related]
22. Hyperglycosylated hCG, a review.
Cole LA
Placenta; 2010 Aug; 31(8):653-64. PubMed ID: 20619452
[TBL] [Abstract][Full Text] [Related]
23. Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment.
Hoekstra AV; Keh P; Lurain JR
J Reprod Med; 2004 Jun; 49(6):447-52. PubMed ID: 15283052
[TBL] [Abstract][Full Text] [Related]
24. Twenty-five years' clinical experience with placental site trophoblastic tumors.
Papadopoulos AJ; Foskett M; Seckl MJ; McNeish I; Paradinas FJ; Rees H; Newlands ES
J Reprod Med; 2002 Jun; 47(6):460-4. PubMed ID: 12092014
[TBL] [Abstract][Full Text] [Related]
25. [Trophoblastic diseases].
ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of tumor markers in gestational trophoblastic diseases.
Ahmad AE; Dehaghani AS; Shaker M; Fattahi MJ
J Reprod Med; 2008 Dec; 53(12):930-4. PubMed ID: 19160651
[TBL] [Abstract][Full Text] [Related]
27. Choriocarcinoma and gestational trophoblastic disease.
Smith HO; Kohorn E; Cole LA
Obstet Gynecol Clin North Am; 2005 Dec; 32(4):661-84. PubMed ID: 16310678
[TBL] [Abstract][Full Text] [Related]
28. Hyperglycosylated hCG: a variant with separate biological functions to regular hCG.
Cole LA; Khanlian SA
Mol Cell Endocrinol; 2007 Jan; 260-262():228-36. PubMed ID: 17081684
[TBL] [Abstract][Full Text] [Related]
29. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
Kohorn EI
Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
[TBL] [Abstract][Full Text] [Related]
30. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases.
Cole LA
Int J Gynecol Cancer; 2014 Nov; 24(9):1709-14. PubMed ID: 25275660
[TBL] [Abstract][Full Text] [Related]
31. The hCG assay in the treatment of trophoblastic disease.
Pattillo RA; Hussa RO
J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
[TBL] [Abstract][Full Text] [Related]
32. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test.
Cole LA; Khanlian SA
Clin Biochem; 2004 May; 37(5):344-9. PubMed ID: 15087248
[TBL] [Abstract][Full Text] [Related]
33. [Placental site trophoblastic tumor].
Piura B; Shaco-Levy R
Harefuah; 2007 Jan; 146(1):62-7, 77. PubMed ID: 17294852
[TBL] [Abstract][Full Text] [Related]
34. The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease.
Benjapibal M; Wataganara T; Senawong S; Boriboonhirunsarn D; Suphanit I
J Med Assoc Thai; 2001 Jul; 84(7):1000-5. PubMed ID: 11759958
[TBL] [Abstract][Full Text] [Related]
35. hCG measurement in gestational trophoblastic neoplasia: a critical appraisal.
Hancock BW
J Reprod Med; 2006 Nov; 51(11):859-60. PubMed ID: 17165429
[No Abstract] [Full Text] [Related]
36. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
Cole LA; Kohorn EI; Kim GS
J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
[TBL] [Abstract][Full Text] [Related]
37. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
38. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
[TBL] [Abstract][Full Text] [Related]
39. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
[TBL] [Abstract][Full Text] [Related]
40. Clinical utility of human chorionic gonadotropin and alpha-subunit measurements.
Hussa RO
Obstet Gynecol; 1982 Jul; 60(1):1-12. PubMed ID: 6283446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
